Terms: = Germ cell tumor AND PDCD1LG2, Q9BQ51, 80380, ENSG00000197646, MGC142240, Btdc, PDCD1L2, CD273, B7DC, MGC142238, PD-L2, PDL2, bA574F11_2 AND Treatment
35681 results:
1. Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.
Xu T; Dillon JS; Maluccio MA; Quelle DE; Nash SH; Cho H; Limbach KE; Skill NJ; Bren-Mattison Y; O'Rorke MA
J Cancer Res Clin Oncol; 2024 Nov; 150(11):485. PubMed ID: 39488644
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis.
Khalafallah AM; Shah KH; Knott MV; Berke CN; Shah AH; Komotar RJ; Ivan ME
Neurosurg Focus; 2024 Nov; 57(5):E3. PubMed ID: 39486051
[TBL] [Abstract] [Full Text] [Related]
3. New emerging treatment options for metastatic melanoma: a systematic review and meta-analysis of skin cancer therapies.
Jarab AS; Al-Qerem WA; Khdour LM; Mimi YA; Khdour MR
Arch Dermatol Res; 2024 Nov; 316(10):735. PubMed ID: 39485529
[TBL] [Abstract] [Full Text] [Related]
4. A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies.
Bielecka-Wajdman AM; Machnik G; Linnebacher C; Linnebacher M; Stec-Grosman K; Obuchowicz E
Front Biosci (Landmark Ed); 2024 Oct; 29(10):364. PubMed ID: 39473426
[TBL] [Abstract] [Full Text] [Related]
5. Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma cell Lines.
Chae Y; Roh J; Im M; Jang W; Kim B; Kang J; Youn B; Kim W
Cancer Genomics Proteomics; 2024; 21(6):608-621. PubMed ID: 39467632
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and pathological characteristics of gastric large cell neuroendocrine carcinoma: A report of 2 cases series and literature review.
Wang B; Si Y; Dou Y; Li Y; Liu Z; Huang C; Xu X
Medicine (Baltimore); 2024 Oct; 103(40):e39851. PubMed ID: 39465709
[TBL] [Abstract] [Full Text] [Related]
7. Functional and oncological outcomes following more than three consecutive surgical resections for multiple relapses of initially grade 2 IDH-mutated gliomas.
Nassihi A; Duffau H
Acta Neurochir (Wien); 2024 Oct; 166(1):425. PubMed ID: 39465448
[TBL] [Abstract] [Full Text] [Related]
8. Managing Limbal Dermoids in Patients with Goldenhar Syndrome: A Case Series.
Tripathi A; Mohan S; Pathak L
Rom J Ophthalmol; 2024; 68(3):306-311. PubMed ID: 39464756
[TBL] [Abstract] [Full Text] [Related]
9. Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma cells.
Teerawonganan P; Hasriadi ; Dasuni Wasana PW; Angsuwattana P; Suksamrarn A; Nalinratana N; Vajragupta O; Towiwat P; Thitikornpong W; Rojsitthisak P
Int J Mol Sci; 2024 Oct; 25(20):. PubMed ID: 39457050
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer Activity of Vitamin D, Lumisterol and Selected Derivatives against Human Malignant Melanoma cell Lines.
Domżalski P; Piotrowska A; Tuckey RC; Zmijewski MA
Int J Mol Sci; 2024 Oct; 25(20):. PubMed ID: 39456696
[TBL] [Abstract] [Full Text] [Related]
11. A novel scoring system proposal to guide surgical treatment indications for high grade gliomas in elderly patients: DAK-75.
Bianconi A; Presta R; La Cava P; De Marco R; Zeppa P; Lacroce P; Castaldo M; Bruno F; Pellerino A; Rudà R; Melcarne A; Garbossa D; Bo M; Cofano F
Neurosurg Rev; 2024 Oct; 47(1):823. PubMed ID: 39453521
[TBL] [Abstract] [Full Text] [Related]
12. Health-Related Quality of Life and treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers.
Fischl A; Gerken M; Lindberg-Scharf P; Haedenkamp TM; Rosengarth K; Hillberg A; Vogelhuber M; Schön I; Proescholdt M; Araceli T; Koller M; Herrmann A; Kölbl O; Pukrop T; Riemenschneider MJ; Schmidt NO; Klinkhammer-Schalke M; Linker R; Hau P; Bumes E
Curr Oncol; 2024 Oct; 31(10):6155-6170. PubMed ID: 39451763
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 cells.
Romani A; Lodi G; Casciano F; Gonelli A; Secchiero P; Zauli G; Bortolini O; Valacchi G; Ragno D; Bondi A; Benedusi M; Esposito E; Voltan R
Cells; 2024 Oct; 13(20):. PubMed ID: 39451196
[TBL] [Abstract] [Full Text] [Related]
14. A Novel ANG-BSA/BCNU/ICG MNPs Integrated for Targeting Therapy of Glioblastoma.
Liu LH; Liu YF; Zhang HB; Liu XL; Zhang HW; Huang B; Lin F; Li WH
Technol Cancer Res Treat; 2024; 23():15330338241281321. PubMed ID: 39444362
[TBL] [Abstract] [Full Text] [Related]
15. Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.
Motahari Z; Lepe JJ; Bautista MR; Hoerig C; Plant-Fox AS; Das B; Fowler CD; Magge SN; Bota DA
PLoS One; 2024; 19(10):e0300411. PubMed ID: 39436961
[TBL] [Abstract] [Full Text] [Related]
16. treatment indicators and prognostic factors in colorectal neuroendocrine neoplasms and adenocarcinoma with neuroendocrine differentiation: a single center retrospective study.
Fu X; Wang C; Yu Y; Chen HN
Int J Colorectal Dis; 2024 Oct; 39(1):170. PubMed ID: 39436458
[TBL] [Abstract] [Full Text] [Related]
17. The value of elective neck irradiation in management of esthesioneuroblastoma: a retrospective study based on propensity score matching.
Zhao Y; Yan L; Li R; Wang X; Zhu Y
Radiat Oncol; 2024 Oct; 19(1):146. PubMed ID: 39434155
[TBL] [Abstract] [Full Text] [Related]
18. Bioinformatics investigation of the prognostic value and mechanistic role of CD9 in glioma.
Jiang J; Jiang B; Li WB
Sci Rep; 2024 Oct; 14(1):24502. PubMed ID: 39424846
[TBL] [Abstract] [Full Text] [Related]
19. Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-γ response pathway activation.
Kobayashi Y; Bustos MA; Hayashi Y; Yu Q; Hoon D
J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39424359
[TBL] [Abstract] [Full Text] [Related]
20. [Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression].
Chuguev AS; Kobyletskaya TM; Gerasimov VA; Belikova AA; Kaprin AD; Datsenko PV
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(5):23-29. PubMed ID: 39422680
[TBL] [Abstract] [Full Text] [Related]
[Next]